\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\ is\\ focused\\ on\\ treatment\\ of\\ the\\ lung\\ cancer\\,\\ and\\ with\\ successful\\ treatment\\ of\\ the\\ primary\\ disease\\,\\ the\\ hypertrophic\\ osteoarthropathy\\ can\\ dramatically\\ improve\\ or\\ resolve\\ completely\\.\ \(0\)\
\-\ whole\\ body\\ osseous\\ scintigraphy\\ was\\ performed\\.\\ \\ no\\ focally\\ intense\\ radiotracer\\ uptake\\ was\\ seen\\ to\\ suggest\\ osteoblastic\\ metastases\\.\\ \\ however\\,\\ irregular\\ periosteal\\ uptake\\ is\\ noted\\ in\\ the\\ femoral\\ diaphyses\\ and\\ metaphyses\\ bilaterally\\.\ \(0\)\
\-\ hypertrophic\\ pulmonary\\ osteoarthropathy\\ \\(based\\ on\\ clinical\\ presentation\\ and\\ radiographic\\ findings\\ only\\)\ \(0\)\
\-\ differential\\ considerations\\ based\\ on\\ scintigraphic\\ appearance\\ may\\ include\\:\\ \\(it\\ should\\ be\\ noted\\ that\\ in\\ this\\ case\\ the\\ scintigraphic\\ appearance\\ virtually\\ excludes\\ the\\ other\\ three\\ entities\\ noted\\ under\\ \\"common\\"\\ ddx\\ possibilities\\.\ \(0\)\
\-\ common\\:\ \(1\)\
\-\ hypertrophic\\ osteoarthropathy\\ \ \(1\)\
\-\ fibrous\\ dysplasia\\ \ \(14\)\
\-\ paget\\ disease\\ \ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ uncommon\\:\ \(0\)\
\-\ caffey\\ disease\\ \ \(0\)\
\-\ acromegaly\ \(4\)\
\-\ endosteal\\ hyperostosis\\ \\(van\\ buchem\\ disease\\)\ \(0\)\
\-\ macrodystrophia\\ lipomatosa\ \(3\)\
\-\ proteus\\ syndrome\ \(0\)\
\-\ 43\\ year\\ old\\ male\\ originally\\ presented\\ with\\ cough\\.\\ \\ chest\\ radiograph\\ showed\\ a\\ left\\ upper\\ lobe\\ consolidation\\ and\\ he\\ was\\ treated\\ with\\ antibiotics\\.\\ \\ he\\ failed\\ a\\ two\\ week\\ course\\ of\\ antibiotics\\ and\\ returned\\ for\\ follow\\ up\\ medical\\ care\\.\\ \\ a\\ chest\\ ct\\ showed\\ a\\ large\\ round\\ irregularly\\ bordered\\ mass\\ in\\ the\\ left\\ upper\\ lobe\\.\\ \\ biopsy\\ of\\ the\\ lesion\\ lead\\ to\\ the\\ diagnosis\\ of\\ adenocarcinoma\\ of\\ the\\ lung\\.\\ \\ the\\ patient\\ then\\ presented\\ to\\ our\\ service\\ for\\ osseous\\ scintigraphy\\ to\\ evaluate\\ for\\ bony\\ metastatic\\ disease\\.\ \(0\)\
\-\ this\\ finding\\ was\\ discovered\\ after\\ the\\ diagnosis\\ of\\ lung\\ carcinoma\\ was\\ made\\ and\\ a\\ bone\\ scan\\ was\\ performed\\ to\\ search\\ for\\ metasases\\.\\ \\ but\\,\\ often\\ patients\\ undergoing\\ bone\\ scan\\ for\\ other\\ reasons\\ are\\ discovered\\ to\\ have\\ \\"ho\\"\\,\\ which\\ leads\\ to\\ the\\ diagnosis\\ of\\ the\\ etiologic\\ entity\\.\ \(0\)\
\-\ in\\ addition\\ to\\ pulmonary\\ diseases\\ \\(which\\ when\\ in\\ association\\ with\\ this\\ periosteal\\ proliferation\\ often\\ results\\ in\\ \\"ho\\"\\ being\\ called\\ \\"hypertrophic\\ pulmonary\\ osteoarthropathy\\"\\)\\,\\ mediastinal\\,\\ cardiovascular\\,\\ and\\ gastrointestinal\\ diseases\\ are\\ often\\ associated\\ with\\ \\"ho\\"\\.\\ \\ the\\ \\"ho\\"\\ can\\ be\\ reversed\\ with\\ elimination\\ of\\ the\\ inciting\\ process\\.\ \(0\)\
\-\ the\\ scintigraphic\\ finding\\ is\\ often\\ evident\\ before\\ radiographic\\ changes\\ are\\ evident\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ho\\:\\ 0\\.29746350880928785\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.2944232003809918\ \(0\)\
\-\ hypertrophic\\:\\ 0\\.24387402584231724\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.19948992544874466\ \(0\)\
\-\ the\\:\\ 0\\.1984589255143403\ \(0\)\
\-\ often\\:\\ 0\\.15270048171711242\ \(0\)\
\-\ disease\\:\\ 0\\.14735228432764128\ \(0\)\
\-\ was\\:\\ 0\\.1223393903872675\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.12151405577602248\ \(0\)\
\-\ to\\:\\ 0\\.11701095528796959\ \(0\)\
\-\ diseases\\:\\ 0\\.10750612767554583\ \(0\)\
\-\ pulmonary\\:\\ 0\\.1069861980144984\ \(0\)\
\-\ lung\\:\\ 0\\.10676951372333936\ \(0\)\
\-\ discovered\\:\\ 0\\.10667721914909636\ \(0\)\
\-\ of\\:\\ 0\\.1030441767952063\ \(0\)\
\-\ periosteal\\:\\ 0\\.10297118999189322\ \(0\)\
\-\ evident\\:\\ 0\\.10057398745101274\ \(0\)\
\-\ buchem\\:\\ 0\\.09356373058148436\ \(0\)\
\-\ metasases\\:\\ 0\\.09356373058148436\ \(0\)\
\-\ osseous\\:\\ 0\\.09339382011208008\ \(0\)\
\-\ noted\\:\\ 0\\.09305928692737146\ \(0\)\
\-\ diagnosis\\:\\ 0\\.09098718971780985\ \(0\)\
\-\ uptake\\:\\ 0\\.0899752679355812\ \(0\)\
\-\ macrodystrophia\\:\\ 0\\.08940513957657818\ \(0\)\
\-\ lipomatosa\\:\\ 0\\.08940513957657818\ \(0\)\
\-\ for\\:\\ 0\\.08866350296250243\ \(0\)\
\-\ in\\:\\ 0\\.08732627070628517\ \(0\)\
\-\ radiographic\\:\\ 0\\.08681322208891958\ \(0\)\
\-\ elimination\\:\\ 0\\.08645457230248464\ \(0\)\
\-\ antibiotics\\:\\ 0\\.08620539406859987\ \(0\)\
\-\ based\\:\\ 0\\.08476024065021123\ \(0\)\
\-\ and\\:\\ 0\\.0846267496558651\ \(0\)\
\-\ proteus\\:\\ 0\\.08416593452147356\ \(0\)\
\-\ treatment\\:\\ 0\\.08360844713380909\ \(0\)\
\-\ etiologic\\:\\ 0\\.08229598129757847\ \(0\)\
\-\ diaphyses\\:\\ 0\\.08071495837424766\ \(0\)\
\-\ caffey\\:\\ 0\\.08071495837424766\ \(0\)\
\-\ excludes\\:\\ 0\\.07934541402348494\ \(0\)\
\-\ bordered\\:\\ 0\\.07934541402348494\ \(0\)\
\-\ dramatically\\:\\ 0\\.07813739029267228\ \(0\)\
\-\ showed\\:\\ 0\\.07793818210734331\ \(0\)\
\-\ finding\\:\\ 0\\.07691355391756005\ \(0\)\
\-\ acromegaly\\:\\ 0\\.07607924192821536\ \(0\)\
\-\ reversed\\:\\ 0\\.07607924192821536\ \(0\)\
\-\ inciting\\:\\ 0\\.07436587720232196\ \(0\)\
\-\ metaphyses\\:\\ 0\\.07161446856250553\ \(0\)\
\-\ possibilities\\:\\ 0\\.07102823201367256\ \(0\)\
\-\ van\\:\\ 0\\.07102823201367256\ \(0\)\
\-\ appearance\\:\\ 0\\.0705419240922118\ \(0\)\
\-\ entities\\:\\ 0\\.06994761796347412\ \(0\)\
\-\ focused\\:\\ 0\\.06944720909034176\ \(0\)\
\-\ scan\\:\\ 0\\.06942184615659101\ \(0\)\
\-\ he\\:\\ 0\\.0692901430088839\ \(0\)\
\-\ performed\\:\\ 0\\.0692246071870426\ \(0\)\
\-\ with\\:\\ 0\\.06873716377752491\ \(0\)\
\-\ focally\\:\\ 0\\.06851417093001322\ \(0\)\
\-\ presented\\:\\ 0\\.06823469754780867\ \(0\)\
\-\ lobe\\:\\ 0\\.06762049912532966\ \(0\)\
\-\ hyperostosis\\:\\ 0\\.06725671892332225\ \(0\)\
\-\ are\\:\\ 0\\.06660102715552996\ \(0\)\
\-\ common\\:\\ 0\\.06635913558777422\ \(0\)\
\-\ endosteal\\:\\ 0\\.06613673304974961\ \(0\)\
\-\ irregularly\\:\\ 0\\.06613673304974961\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.06545272314470738\ \(0\)\
\-\ virtually\\:\\ 0\\.06545272314470738\ \(0\)\
\-\ metastatic\\:\\ 0\\.064175159833493\ \(0\)\
\-\ bone\\:\\ 0\\.06384532584740675\ \(0\)\
\-\ entity\\:\\ 0\\.06363806033716009\ \(0\)\
\-\ proliferation\\:\\ 0\\.0628384596844744\ \(0\)\
\-\ upper\\:\\ 0\\.06252933366662612\ \(0\)\
\-\ reasons\\:\\ 0\\.062096713855549296\ \(0\)\
\-\ resolve\\:\\ 0\\.06186092537021592\ \(0\)\
\-\ chest\\:\\ 0\\.0617647969208269\ \(0\)\
\-\ whole\\:\\ 0\\.0614050126510135\ \(0\)\
\-\ can\\:\\ 0\\.0614041248635762\ \(0\)\
\-\ search\\:\\ 0\\.06096850646057931\ \(0\)\
\-\ other\\:\\ 0\\.060766145131460676\ \(0\)\
\-\ considerations\\:\\ 0\\.0605498219034633\ \(0\)\
\-\ service\\:\\ 0\\.0605498219034633\ \(0\)\
\-\ this\\:\\ 0\\.060311081023900266\ \(0\)\
\-\ originally\\:\\ 0\\.05957228758920482\ \(0\)\
\-\ failed\\:\\ 0\\.0590275747707499\ \(0\)\
\-\ leads\\:\\ 0\\.0590275747707499\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.0590275747707499\ \(0\)\
\-\ paget\\:\\ 0\\.058017939186485776\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.05770233436530973\ \(0\)\
\-\ successful\\:\\ 0\\.05680991545567313\ \(0\)\
\-\ improve\\:\\ 0\\.05680991545567313\ \(0\)\
\-\ ddx\\:\\ 0\\.05560189172486047\ \(0\)\
\-\ intense\\:\\ 0\\.05522889253234232\ \(0\)\
\-\ returned\\:\\ 0\\.05498755557654957\ \(0\)\
\-\ 43\\:\\ 0\\.054751767091216194\ \(0\)\
\-\ called\\:\\ 0\\.05463587492713407\ \(0\)\
\-\ consolidation\\:\\ 0\\.05407527926014075\ \(0\)\
\-\ which\\:\\ 0\\.0532064636276722\ \(0\)\
\-\ undergoing\\:\\ 0\\.053137498280123534\ \(0\)\
\-\ on\\:\\ 0\\.05300939194229692\ \(0\)\
\-\ uncommon\\:\\ 0\\.052940254751331225\ \(0\)\
\-\ association\\:\\ 0\\.052651324450766944\ \(0\)\
\-\ completely\\:\\ 0\\.05227832525824879\ \(0\)\
\-\ lead\\:\\ 0\\.05209679224679031\ \(0\)\
\-\ our\\:\\ 0\\.051830378634510156\ \(0\)\
\-\ radiotracer\\:\\ 0\\.05107030152743614\ \(0\)\
\-\ under\\:\\ 0\\.048429617262713914\ \(0\)\
\-\ is\\:\\ 0\\.04806674528845667\ \(0\)\
\-\ round\\:\\ 0\\.04793820124188413\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04781894004469547\ \(0\)\
\-\ suggest\\:\\ 0\\.04752671664813435\ \(0\)\
\-\ be\\:\\ 0\\.04746703967514769\ \(0\)\
\-\ addition\\:\\ 0\\.047355297381104534\ \(0\)\
\-\ metastases\\:\\ 0\\.04729878843708581\ \(0\)\
\-\ before\\:\\ 0\\.04729878843708581\ \(0\)\
\-\ mediastinal\\:\\ 0\\.047242589132670244\ \(0\)\
\-\ results\\:\\ 0\\.04558975951653876\ \(0\)\
\-\ evaluate\\:\\ 0\\.04549479265847096\ \(0\)\
\-\ fibrous\\:\\ 0\\.04544763695520036\ \(0\)\
\-\ irregular\\:\\ 0\\.045169166979249074\ \(0\)\
\-\ made\\:\\ 0\\.04512348161465121\ \(0\)\
\-\ bony\\:\\ 0\\.04507799884657073\ \(0\)\
\-\ dysplasia\\:\\ 0\\.044809258212750475\ \(0\)\
\-\ process\\:\\ 0\\.04388006498119947\ \(0\)\
\-\ cough\\:\\ 0\\.04368012985092367\ \(0\)\
\-\ femoral\\:\\ 0\\.04348401780731029\ \(0\)\
\-\ course\\:\\ 0\\.04321561209103357\ \(0\)\
\-\ care\\:\\ 0\\.04180357878351125\ \(0\)\
\-\ then\\:\\ 0\\.04141527951171738\ \(0\)\
\-\ biopsy\\:\\ 0\\.04101057597434289\ \(0\)\
\-\ being\\:\\ 0\\.040769239018550146\ \(0\)\
\-\ presentation\\:\\ 0\\.04027451075890779\ \(0\)\
\-\ left\\:\\ 0\\.03991530248073197\ \(0\)\
\-\ week\\:\\ 0\\.03935135942657127\ \(0\)\
\-\ three\\:\\ 0\\.03927375743673341\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03901924444160047\ \(0\)\
\-\ cancer\\:\\ 0\\.038969091053671655\ \(0\)\
\-\ body\\:\\ 0\\.03850448098614732\ \(0\)\
\-\ should\\:\\ 0\\.038175120429278106\ \(0\)\
\-\ radiograph\\:\\ 0\\.03810589847431787\ \(0\)\
\-\ differential\\:\\ 0\\.038014323335651495\ \(0\)\
\-\ medical\\:\\ 0\\.037182863579576994\ \(0\)\
\-\ clinical\\:\\ 0\\.037078312751771064\ \(0\)\
\-\ only\\:\\ 0\\.03655119076078957\ \(0\)\
\-\ treated\\:\\ 0\\.03643330041232069\ \(0\)\
\-\ primary\\:\\ 0\\.035974839848764345\ \(0\)\
\-\ changes\\:\\ 0\\.035358548807205556\ \(0\)\
\-\ when\\:\\ 0\\.03534097151516729\ \(0\)\
\-\ syndrome\\:\\ 0\\.0352709620461059\ \(0\)\
\-\ carcinoma\\:\\ 0\\.034995607323160975\ \(0\)\
\-\ include\\:\\ 0\\.034810500048765465\ \(0\)\
\-\ two\\:\\ 0\\.034744008098578846\ \(0\)\
\-\ however\\:\\ 0\\.034628674462749656\ \(0\)\
\-\ patients\\:\\ 0\\.03291278944015013\ \(0\)\
\-\ follow\\:\\ 0\\.03153978069232895\ \(0\)\
\-\ associated\\:\\ 0\\.03083701631825479\ \(0\)\
\-\ it\\:\\ 0\\.029948371593534372\ \(0\)\
\-\ may\\:\\ 0\\.029442032481789848\ \(0\)\
\-\ case\\:\\ 0\\.029392746719509946\ \(0\)\
\-\ large\\:\\ 0\\.02931437883187547\ \(0\)\
\-\ have\\:\\ 0\\.029226924842464322\ \(0\)\
\-\ up\\:\\ 0\\.028940682616189834\ \(0\)\
\-\ but\\:\\ 0\\.0289312774368109\ \(0\)\
\-\ findings\\:\\ 0\\.02887502676165856\ \(0\)\
\-\ after\\:\\ 0\\.028382189285430747\ \(0\)\
\-\ lesion\\:\\ 0\\.02804904786094744\ \(0\)\
\-\ seen\\:\\ 0\\.027544121587140074\ \(0\)\
\-\ male\\:\\ 0\\.026049093925516437\ \(0\)\
\-\ that\\:\\ 0\\.025389382740519648\ \(0\)\
\-\ mass\\:\\ 0\\.022347706233421263\ \(0\)\
\-\ ct\\:\\ 0\\.02227375964493866\ \(0\)\
\-\ or\\:\\ 0\\.02035317382052763\ \(0\)\
\-\ patient\\:\\ 0\\.019029044351206177\ \(0\)\
\-\ no\\:\\ 0\\.019025465098894856\ \(0\)\
\-\ year\\:\\ 0\\.018030378003776985\ \(0\)\
\-\ old\\:\\ 0\\.017315404253861348\ \(0\)\
